Qualitative study into quality of life issues surrounding insulin pump use in type 1 diabetes
Authors:
Open Access
- 1 April 2007
- journal article
- research article
- Published by Wiley in Practical Diabetes International
- Vol. 24 (3) , 143-148
Abstract
Currently, there is a need for qualitative research about how insulin pump therapy changes quality of life, which is significant to people with type 1 diabetes. This study aimed to elicit the experiences of current insulin pump users in order to discover the therapy's benefits, downsides and effect on their quality of life. A qualitative approach was taken in order to reveal subjective experiences. This research will inform future research and assist with policy and guideline development by health care providers about pump therapy.Participants were briefly interviewed by telephone about their experiences of living with an insulin pump. Four questions were asked. These covered the benefits of pump use, effects on quality of life, whether participants experienced downsides to using a pump and any other issues participants wished to raise.In all, 80 insulin pump users participated in the study. All 80 reported experiencing benefits; insulin pump use had improved their quality of life. Key positive themes emerging from the data included greater control (45), flexibility (33), freedom (28), family effects (seven), convenience (seven) and independence (five). Key drawbacks emerging from the data included visibility— device (25), breakdown (17), visibility— skin (five) and cost (three).Participants overwhelmingly reported experiencing benefits and improvements in their quality of life associated with insulin pump use. These pump users remain on pump therapy by choice, so the benefits clearly outweigh the downsides. However, further work needs to determine if these downsides contribute to explaining why 2–4% of pump users discontinue pump use after a short period of time, or whether this is a result of other factors. Copyright © 2007 John Wiley & Sons.Keywords
This publication has 11 references indexed in Scilit:
- Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist serviceDiabetic Medicine, 2005
- A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: a prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusionDiabetes Research and Clinical Practice, 2004
- Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injection Regimens in Children With Type 1 Diabetes: A Randomized Open Crossover TrialPediatrics, 2003
- Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 yearsDiabetic Medicine, 2002
- Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of lifeDiabetic Medicine, 2002
- Intensive Insulin Therapy With Insulin LisproDiabetes Care, 2001
- Effect of patient-selected intensive insulin therapy on quality of lifePatient Education and Counseling, 1997
- Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications TrialThe Journal of Pediatrics, 1994
- Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT)Diabetes Care, 1988
- Fear of Hypoglycemia: Quantification, Validation, and UtilizationDiabetes Care, 1987